Author

Antonio Rodríguez-Calero

University of BernORCID 0000-0002-2744-2381Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Approach:experimental assay· 2 Research Focus:gene regulatory network inference· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Mark A. RubiniD· 2 shared Simone de BrotiD· 2 shared Achim Aigner· 1 shared Ainsley Mike AntaoiD· 1 shared Alessandro VasciaveoiD· 1 shared Alexander ChuiiD· 1 shared Alexander EweiD· 1 shared Alexander L.E. WangiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Mark A. RubinORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyThe Journal of Experimental MedicinePeer-reviewedApr 28, 2026

A forward genetic screen identifies Sirtuin1 as a driver of neuroendocrine prostate cancer

Francisca Nunes de Almeida, Alessandro Vasciaveo, Arianna Giacobbe…·Cory T. Abate-Shen

The paper uses a forward genetic screen in a mouse model to identify Sirtuin1 as a driver of neuroendocrine prostate cancer, showing its role in promoting NEPC and potential as a therapeutic target.

2 citations

mousebulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintDec 13, 2025

Blocking Minor Intron Splicing Disrupts DNA Repair and Overcomes Therapy Resistance in Prostate and Breast Cancer

Anke Augspach, Paola Francica, Kaitlin N. Girardini…·Mark A. Rubin

This study shows that targeting the minor spliceosome, specifically U6atac snRNA, disrupts DNA repair and overcomes therapy resistance in prostate and breast cancers.

DOI 10.64898/2025.12.10.693392

humanDNA methylation

𝕏 PostBluesky